• No results found

Nissui Glucose Fermentative Gram Negative Rod Identification System EB 20 Gives a Unique Profile for Typical Non Sorbitol Fermenting Escherichia coli O157:H7

N/A
N/A
Protected

Academic year: 2020

Share "Nissui Glucose Fermentative Gram Negative Rod Identification System EB 20 Gives a Unique Profile for Typical Non Sorbitol Fermenting Escherichia coli O157:H7"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Nissui Glucose Fermentative Gram-Negative Rod Identification System

EB-20 Gives a Unique Profile for Typical Non-Sorbitol-Fermenting

Escherichia coli

O157:H7

H. Kodaka,

1,2

* Y. Uesaka,

2

and F. Kashitani

1

Department of Microbiology, School of Medicine, Toho University, Otaku, Tokyo 143-8540,1and

Nissui Pharmaceutical Co. Ltd., Yuki, Ibaraki 307-0036,2Japan

Received 28 May 2003/Returned for modification 10 September 2003/Accepted 1 October 2003

The 98 non-sorbitol-fermenting (NSF) Escherichia coli O157:H7 strains identified on a Nissui glucose fermentative gram-negative rod identification system (EB-20) gave a unique biochemical profile number that was not detected in 85 pathogenic and 13 nonpathogenic E. coli strains. Thus, EB-20 is useful for the identification of NSF E. coli O157:H7 and provides a simple, cost-effective, and reliable tool for clinical laboratories.

Shiga toxin-producingEscherichia coli(STEC) is one of five currently recognized groups ofE. colithat cause several dis-tinct clinical syndromes associated with infectious bacterial gastroenteritis, andE. coli O157 is the most commonly iden-tified diarrheagenicE. coliisolate in North America and Eu-rope (7). Since STEC O157:H7 emerged as a public health threat following its initial identification as a pathogen in a 1982 outbreak of illness associated with the consumption of under-cooked ground beef (26), it has been reported as a food-borne pathogen throughout the world. In Japan, the first outbreak of STEC O157:H7 was reported in a kindergarten in Saitama in 1990 (17). Since the report of an outbreak of STEC O157:H7 infection among schoolchildren in Japan in 1996 (32), the number of STEC serotypes of non-O157:H7E. colisuch asE. coliO26 (H11, nonmotile [NM]; and H not tested) and sero-type O111 (NM, H not tested, and H unsero-typeable [UT]) have also increased in Japan (20). However, STEC O157:H7 has remained the predominant STEC serotype in Japan since 1996. The use of Shiga toxin detection assays to screen stool samples for STEC has previously been reported (25); however, these assays are not dependent on a particular bacterial serotype. Therefore, it is necessary to isolate the bacterium from the sample after detection of the toxin and to perform biochemical and serological identification for reporting. During an out-break of food-borne disease, large numbers of samples must be tested, and a simple identification method is needed. Cur-rently, the most rapid and accurate Shiga toxin detection assays such as the PCR (5, 8) and rapid immunoassay (24) can be carried out in large clinical laboratories. However, these so-phisticated assays are not suitable for detection of a particular bacterial serotype and are often not readily applicable for use in small clinical microbiology laboratories where simple and low-cost methods are needed. At a typical Japanese local health center, there is almost no automated equipment for

optical scanning and interpreting and analyzing results for the identification of gram-negative bacilli. The detection ofE. coli

O157:H7 is based on its recovery from samples and the pres-ence of its virulpres-ence-associated factors (verocytotoxins) or the detection of its O157 antigens (8, 28, 30). Selective media for isolatingE. coliO157:H7 strains rely on the fact that most of these strains display characteristic biochemical reactions (30): no␤-glucuronidase activity and no sorbitol (SOR) fermenta-tion within 24 h at 37°C, except for some German or U.S. strains (11, 12). However, these last two biochemical features are not commonly used in routine clinical and food laborato-ries because of the simplicity of well-established commercial identification systems. The use of these systems on

presump-tiveE. colistrains offers not only the advantage of confirming

strains at the genus and/or species level but also the possibility of detecting the presence of STEC O157:H7 by identifying profiles that are unique to these strains. It has been reported that a few profiles generated by the API 20E identification system strongly suggestE. coliO157 (10) and that MicroScan generates one of two profiles with more than 90% of the strains

ofE. coliO157 (1). Results obtained from the ID 32E system

showed atypical biochemical reactions but accurate identifica-tion at the species level and no unique biochemical profile numbers for E. coliO157, although these numbers were dis-tinct from those of other serotypes (18). In this study, we evaluated the Nissui glucose fermentative gram-negative rod identification system (EB-20; Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) for STEC, enterotoxigenicE. coli(ETEC), en-teropathogenicE. coli(EPEC), and nonpathogenicE. coli. We also tested separately for the presence of ␤-glucuronidase in these strains. The presence of ␤-glucuronidase in E. coli is about 96 (9) to 97% (13). However,E. coliserotype O157:H7, which causes hemorrhagic colitis, has been reported to be

␤-glucuronidase negative (16). Serotypes O111 and O1 have also been reported to be␤-glucuronidase negative (16). During the last decade, we have used the EB-20 system to study many intestinal bacteria isolated from clinical specimens and food samples. EB-20 is able to differentiate E. coliO157:H7 from pathogenic and nonpathogenicE. coli.

* Corresponding author. Mailing address: Nissui Pharmaceutical Co. Ltd., 1075-2 Hokunanmoro, Yuki, Ibaraki 307-0036, Japan. Phone: 81-296-35-1225. Fax: 81-296-35-1579. E-mail: [email protected] -pharm.jp.

354

on May 15, 2020 by guest

http://jcm.asm.org/

Downloaded from

on May 15, 2020 by guest

http://jcm.asm.org/

Downloaded from

on May 15, 2020 by guest

http://jcm.asm.org/

(2)

(Part of this study ofE. coliO157:H7 with the EB-20 iden-tification system and the ␤-glucuronidase test has been pre-sented previously [H. Kodaka, Y. Uesaka, S. Mizuochi, and K. Horigome, Abstr. 91st Gen. Meet. Am. Soc. Microbiol., abstr. C-290, 1991].)

A total of 183 strains of diarrheagenicE. coliand 13 strains of nonpathogenic E. coli were tested with conventional bio-chemical tests and the EB-20 system at 37°C. These strains, from the American Type Culture Collection (ATCC; Rock-ville, Md.), the Osaka Prefectural Institute of Public Health (Osaka, Japan), Nagasaki University attached to the Institute of Tropical Medicine (Nagasaki, Japan), Toho University at-tached to Omori Hospital (Tokyo, Japan), the Tokyo Metro-politan Research Laboratory of Public Health (Tokyo, Japan), and the National Institute of Infectious Diseases, were assem-bled at Nissui Pharmaceutical Co. Ltd. The strains were as follows: (i) 6 ATCCE. coliO157:H7 strains, of which ATCC 43888 does not produce either Shiga-like toxin I or II and does not possess the genes for these toxins; (ii) 13 nonpathogenicE. coli strains from ATCC; (iii) 92 Japanese STEC O157:H7 strains from the Tokyo Metropolitan Research Laboratory of Public Health (6 strains), Toho University (2 strains), and the National Institute of Infectious Diseases (84 strains); (iv) 3 STEC O26:H11 strains and 3 STEC O111:NM strains from the Tokyo Metropolitan Research Laboratory of Public Health; (v) 8 EPEC strains from Nagasaki University; and (vi) 71 ETEC strains (24 heat-labile enterotoxin [LT]-producing strains comprising 12 strains from Nagasaki University, 10 strains from the Osaka Prefectural Institute of Public Health, and 2 strains from the National Institute of Infectious Dis-eases; 26 heat-stable enterotoxin [ST]-producing strains com-prising 16 strains from Nagasaki University, 9 strains from the Osaka Prefectural Institute of Public Health, and 1 strain from the National Institute of Infectious Diseases; and 21 [LT-ST]-producing strains comprising 9 strains from Nagasaki Univer-sity, 10 strains from the Osaka Prefectural Institute of Public Health, and 2 strains from the National Institute of Infectious Diseases).

Conventional methods.All strains were tested by standard methods (4, 19). The␤-glucuronidase assay using 5-bromo-4-chloro-3-indolyl-␤-D-glucuronide cyclohexylammonium salt and 4-methylumbellifery-␤-D-glucuronide (29) and the ␤ -ga-lactosidase assay using 5-bromo-3-indolyl-␤-D-galactoside and 4-methylumbellifery-␤-D-galactoside were carried out. The concentration of each chromogenic substrate was 0.01% (15).

EB-20.The EB-20 test (Fig. 1) was inoculated, incubated at 37°C for about 18 to 20 h, and interpreted as recommended by the manufacturer. The EB-20 test required the oxidase and motility test results for organism identification. The EB-20 test menus of esculin (ESC), phenylalanine deaminase (PPA), ma-lonate (MALO), adonitol (ADO), and raffinose (RAFF) differ from the menus of tryptophane deaminase (TDA), gelatinase, glucose, melibiose (MEL), and amygdalin for the API 20E test. The EB-20 biochemical menu of PPA and mannose differs also from the menus of glucose, MEL, TDA acetamide, tartaric acid, and nitrate for the MicroScan gram-negative rod panel.

Bacterial toxin detection.The ETEC strains were tested for the production of an ST by an enzyme-linked immunoassay (ELISA) (27) and for production of an LT by the bead ELISA

(21) or the sandwich ELISA (2). Shiga toxins or verocytotoxins were tested at other places.

E. coliserotyping.The serotyping for ETEC and EPEC were

based on a positive agglutination reaction using 43 kinds of O (somatic) and 22 kinds of H (flagellum) antigen antisera forE. coli (Denka Seiken Co. Ltd., Tokyo, Japan). The O and H antigens of all strains were examined with the antisera by slide agglutination tests and tube agglutination tests, respectively. The presence of flagellar antigens was determined by flagella staining (14) before the H antigen testing.

We tested 183E. coli strains that caused diarrhea and 13 strains of nonpathogenicE. coliwith the EB-20 system accord-ing to the manufacturer’s instructions. Of the 98 E. coli

O157:H7 strains tested, 98 (100%) generated a biochemical profile number (0151453) that was not observed among any of the other non-O157:H7 strains tested (Table 1). This profile consisted of positive reactions for indole, lysine decarboxylase, ornithine decarboxylase, o-nitrophenyl-␤-D-galactopyranoside (ONPG), RAFF, rhamnose (RHA), sucrose (SUC), mannose, and arabinose and negative reactions for hydrogen sulfide,

FIG. 1. Nissui identification test EB-20. Test wells include the fol-lowing: hydrogen sulfide (H2S), ESC, PPA, indole (IND),

Voges-Proskauer (VP), citrate (CIT), lysine decarboxylase (LDC), arginine dihydrolase (ADH), ornithine decarboxylase (ODC), ONPG, urease (URE), MALO, ADO, inositol (INO), RAFF, RHA, SOR, SUC, and arabinose (ARA). The oxidase and motility tests were performed sep-arately.

on May 15, 2020 by guest

http://jcm.asm.org/

(3)

ESC, PPA, Voges-Proskauer, citrate, arginine dehydrolase, urease, MALO, ADO, inositol, and SOR. AllE. coliO157:H7 strains were␤-glucuronidase negative. Two EPEC strains, 12 LT-producing strains, 3 ST-producing strains, and 13 LT-ST-producing strains were also ␤-glucuronidase negative. All E. coliO157:H7 strains were negative for SOR. One EPEC and one LT-ST-producing strain were also negative for SOR. All LT-producing and ST-producing strains were SOR positive. Two strains other thanE. coliO157:H7 were both SOR and

␤-glucuronidase negative (one EPEC and one LT-ST-produc-ing strain). The serotypLT-ST-produc-ing and EB-20 profile numbers gener-ated were OUT:NM and 0111453, respectively, for the EPEC

strain and O25:NM and 0151003, respectively, for the LT-ST-producing strains. Three STEC O26:H11 strains generated the profile 0151463, and three STEC O111:NM strains generated profile numbers 0101473 and 0141433. The 13 ATCC non-pathogenicE. colistrains were not identified as 0151453. Dur-ing this study for pathogenic and nonpathogenicE. colistrains, we got 37 different profile numbers with the EB-20 system. When the penultimate digit in the EB-20 profile is 5, this identifies the strain as RHA positive, SOR negative, and SUC positive; the profiles of one EPEC strain and 98 E. coli

O157:H7 strains were recognized in this way.

[image:3.603.45.541.80.478.2]

The 0151453 profile generated by EB-20 was not observed in

TABLE 1. Frequency of EB-20 profile numbers of STEC, EPEC, ETEC, and nonpathogenicE. coli

Profile no.a

No. (%) of profile frequencies

STEC

EPEC (n⫽8)e

ETEC Nonpathogenic

E.coli (n⫽13)b

O157:H7

(n⫽6)b (O157:H7n92)c O26:H11(n3)d O111:NM(n3)d LT (n⫽24)f ST (n⫽26)g (nLT-ST21)h

0011013 0 0 0 0 0 0 1 (4) 0 0

0101033 0 0 0 0 1 (13) 6 (25) 0 0 0

0101433 0 0 0 0 0 2 (8) 0 0 0

0101473 0 0 0 1 (33) 0 0 0 0 0

0111023 0 0 0 0 0 0 0 1 (5) 0

0111033 0 0 0 0 5 (63) 0 2 (8) 1 (5) 1 (8)

0111133 0 0 0 0 0 1 (4) 0 0 0

0111413 0 0 0 0 0 0 1 (4) 0 0

0111423 0 0 0 0 0 0 0 1 (5) 0

0111433 0 0 0 0 0 1 (4) 0 1 (5) 0

0111453 0 0 0 0 1 (13) 0 0 0 0

0111473 0 0 0 0 1 (13) 0 0 0 0

0111523 0 0 0 0 0 0 0 1 (5) 0

0141423 0 0 0 0 0 0 1 (4) 0 0

0141433 0 0 0 2 (67) 0 0 0 0 0

0141473 0 0 0 0 0 0 1 (4) 0 0

0150013 0 0 0 0 0 0 0 0 1 (8)

0151033 0 0 0 0 0 2 (8) 0 1 (5) 5 (38)

0151413 0 0 0 0 0 2 (8) 0 0 0

0151433 0 0 0 0 0 1 (4) 1 (4) 6 (29) 3 (23)

0151453 6 (100) 9 (100) 0 0 0 0 0 0 0

0151463 0 0 3 (100) 0 0 0 0 0 0

0151473 0 0 0 0 0 3 (13) 10 (39) 1 (5) 0

0151533 0 0 0 0 0 0 1 (4) 0 0

0153033 0 0 0 0 0 0 0 0 1 (8)

2101033 0 0 0 0 0 1 (4) 0 1 (5) 0

2101123 0 0 0 0 0 0 0 1 (5) 0

2101133 0 0 0 0 0 0 0 1 (5) 0

2111032 0 0 0 0 0 0 0 1 (5) 0

2111033 0 0 0 0 0 1 (4) 1 (4) 1 (5) 0

2111073 0 0 0 0 0 0 1 (4) 0 0

2111123 0 0 0 0 0 0 1 (4) 2 (10) 0

2111133 0 0 0 0 0 2 (8) 1 (4) 0 0

2151033 0 0 0 0 0 1 (4) 0 0 1 (8)

2151433 0 0 0 0 0 0 1 (4) 1 (5) 0

2151471 0 0 0 0 0 0 0 0 1 (8)

2151473 0 0 0 0 0 1 (4) 3 (12) 0 0

aThese numbers represent a tabulation of positive biochemical results based on EB-20 analysis. bStrains from ATCC.

cJapanese strains: 84 strains from the National Institute of Infectious Diseases, 6 strains from the Tokyo Metropolitan Research Laboratory of Public Health, and

2 strains from Toho University.

dStrains from Tokyo Metropolitan Research Laboratory of Public Health. eStrains from Nagasaki University.

fTwelve strains from Nagasaki University, 10 strains from the Osaka Prefectural Institute of Public Health, and 2 strains from the National Institute of Infectious

Diseases.

gSixteen strains from Nagasaki University, nine strains from the Osaka Prefectural Institute of Public Health, and one strain from the National Institute of Infectious

Diseases.

hNine strains from Nagasaki University, 10 strains from the Osaka Prefectural Institute of Public Health, and 2 strains from the National Institute of Infectious

Diseases.

on May 15, 2020 by guest

http://jcm.asm.org/

(4)

the identification code of the 619 Enterobacteriaceae strains including 344E. colistrains isolated from 3,562 urine samples during a previous study (15). A result with the combination of SOR negative, RAFF positive, and ␤-glucuronidase negative was reported by Krishnan et al. to be O157:H7 (16), but we found one EPEC (OUT:NM) with the same combination. The 98 non-sorbitol-fermenting (NSF) E. coli O157:H7 isolates were␤-glucuronidase negative, SUC positive, dulcitol (DUL) positive, SOR negative, and RAFF positive. However, it has been reported that some strains of E. coli O157:H7 do not ferment DUL (16). The EB-20 system does not contain DUL. Therefore, if the strain does not ferment DUL, the profile number would remain the same. Of 91 strains isolated from sporadic or intrafamilial cases in Japan, 82 strains (90.1%) were ␤-glucronidase negative, SOR negative, DUL positive, SUC positive, and RHA positive; 8 strains (8.8%) were␤ -glu-cronidase negative, SOR negative, DUL positive, SUC nega-tive and RHA posinega-tive; and 1 strain (1.1%) was␤-glucronidase negative, SOR negative, DUL negative, SUC positive, and RHA positive (17).E. coliO157:H7 strains which do not fer-ment DUL were not obtained and therefore not tested in this study.

The identification of NSFE. coliO157:H7 by the EB-20 test

wasE. coliinactive (23), which refers to biochemically inactive

strains of an E. coli group formerly known as Alkalescens-Dispar (22). This identification is inconsistent with E. coli

O157:H7 because E. coli inactive is not usually motile. The

␤-glucuronidase test in not included in the EB-20 system, and so it must be done separately, but the test is not always useful because positive ␤-glucuronidase strains of STEC O157:H7 have been reported (11). Of 188 serotype O157 strains exam-ined, 166 isolates were␤-glucuronidase negative and verocy-totoxin positive, while the remaining 22 isolates were all␤ -glu-curonidase positive and verocytotoxin negative (29). According to the report, most (91.9%) of theE. coliO157:H7 strains had the same biotype according to the API 20E test, and a few failed to ferment either SUC (2.7%) or RHA (5.4%) (10). The EB-20 test menu of ESC, PPA, MALO, ADO, and RAFF differs from the API 20E test menu of TDA, gelatinase, glu-cose, MEL, and amygdalin. Although all STEC O157:H7 strains had the same profile on the EB-20 test in this study,E. coliO157:H7 strains that fail to ferment SUC or RHA would have a different profile. Therefore, if the strains that failed to ferment SOR are identified asE. coli, the slide agglutination test forE. coli O157 and the␤-glucuronidase test should be carried out. Based on 657 strains ofE. coliO157:H7 identified between 1995 and 1999, a total of 34 strains (5.2%) were aberrant strains (31); however, the aberrant strains are also clinically important and not negligible. We agree with Ware et al. (31) that direct detection of Shiga toxin-producing strains may be the future method of choice if it is financially feasible. Even though SOR-fermenting STEC O157:NM strains have been reported in sporadic cases (6) and outbreaks (3), the SOR-negative and ␤-glucronidase-negative E. coli O157:H7 strain is still the most predominant organism.

The incorporation of this unique biochemical profile could inform users of the presumptive identification of the typical

NSF E. coli O157:H7 strain and should suggest additional

confirmation tests to be performed, such as the slide aggluti-nation test forE. coli O157 and the ␤-glucuronidase test. If

NSFE. coliO157:H7 strains with aberrant biochemical

prop-erties that would lead to other profiles are identified asE. coli, the slide agglutination test for E. coliO157 and the␤ -glucu-ronidase test should also be carried out. The strain with aber-rant biochemical properties should be sent to a reference lab-oratory for the important confirmation of the production of Shiga toxins. It is nonetheless important that there be a rela-tively simple and inexpensive technique for discriminatingE. colistrains, which would be especially useful for laboratories which do not have an automated system that can take readings hourly by optical scanning and interpret and analyze results for the identification of the bacteria.

Grateful acknowledgment is made to Keizo Yamaguchi of the Toho University School of Medicine for constant interest and guidance in this study. We acknowledge Akemi Kai, Tokyo Metropolitan Research Laboratory of Public Health, and Kazumichi Tamura, National Insti-tute of Infectious Diseases, for providing cultures of pathogenicE. coli. We thank Kazuki Horigome for helpful suggestions and Arnold G. Steigerwalt (Centers for Disease Control and Prevention, Atlanta, Ga.) for critically reading the text.

REFERENCES

1. Abbott, S. L., D. F. Hanson, T. D. Felland, S. Connell, A. H. Shum, and J. M. Janda.1994.Escherichia coliO157:H7 generates a unique biochemical pro-file on MicroScan conventional gram-negative identification panels. J. Clin. Microbiol.32:823–824.

2. Almedia, R. J., F. W. Hickman-Brenner, E. G. Sowers, N. D. Puhr, J. J. Farmer III, and I. K. Wachsmuth.1990. Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J. Clin. Microbiol.28:128–130.

3. Ammon, A., L. R. Petersen, and H. Karch.1999. A large outbreak of hemo-lytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coliO157:H⫺. J. Infect. Dis.179:1274–1277.

4. Barrow, G. I., and R. K. A. Feltham.1993. Cowan and Steel’s manual for the identification of medical bacteria, 3rd ed. Cambridge University Press, Lon-don, England.

5. Be´langer, S. D., M. Boissinot, C. Me´nard, F. J. Picard, and M. G. Bergeron.

2002. Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler. J. Clin. Microbiol.40:

1436–1440.

6. Bielaszewska, M., H. Schmidt, M. A. Karmali, R. Khakhria, J. Janda, K. Bla´hova´, and H. Karch.1998. Isolation and characterization of sorbitol-fermenting Shiga toxin (verocytotoxin)-producingEscherichia coli O157:H-strains in the Czech Republic. J. Clin. Microbiol.36:2135–2137.

7. Bopp, C. A., F. W. Brenner, J. G. Wells, and N. A. Strockbine.1999. Esch-erichia,Shigella, andSalmonella, p. 459–474.InP. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.

8. Desmarchelier, P. M., S. S. Bilge, N. Fegan, L. Mills, J. C. Vary, Jr., and P. I. Tarr.1998. A PCR specific forEscherichia coliO157 based on therfblocus encoding O157 lipopolysaccharide. J. Clin. Microbiol.36:1801–1804. 9. Feng, P. C. S., and P. A. Hartman.1982. Fluorogenic assays for immediate

confirmation ofEscherichia coli. Appl. Environ. Microbiol.43:1320–1329. 10. Haldane, D. J. M., M. A. S. Damm, and J. D. Anderson.1986. Improved

biochemical screening procedure for small clinical laboratories for Vero (Shiga-like)-toxin-producing strains ofEscherichia coli O157:H7. J. Clin. Microbiol.24:652–653.

11. Hayes, P. S., K. Blom, P. Feng, J. Lewis, N. A. Strockbine, and B. Swami-nathan.1995. Isolation and characterization of a␤-D -glucuronidase-produc-ing strain ofEscherichia coliserotype O157:H7 in the United States. J. Clin. Microbiol.33:3347–3348.

12. Karch, H., H. Bo¨hm, H. Schmidt, F. Gunzer, S. Aleksic, and J. Heesemann.

1993. Clonal structure and pathogenicity of Shiga-like toxin-producing, sor-bitol-fermentingEscherichia coliO157:H⫺. J. Clin. Microbiol.31:1200–1205. 13. Kilian, M., and P. Bu¨low.1976. Rapid diagnosis ofEnterobacteriaceae. I. Detection of bacterial glycosidases. Acta Pathol. Microbiol. Scand. Sect. B

84:245–251.

14. Kodaka, H., A. Y. Armfield, G. L. Lombard, and V. R. Dowell, Jr.1982. Practical procedure for demonstrating bacterial flagella. J. Clin. Microbiol.

16:948–952.

15. Kodaka, H., M. Ishikawa, M. Iwata, F. Kashitani, S. Mizuochi, and K. Yamaguchi.1995. Evaluation of new medium with chromogenic substrates for members of the familyEnterobacteriaceaein urine samples. J. Clin. Microbiol.33:199–201.

on May 15, 2020 by guest

http://jcm.asm.org/

(5)

16. Krishnan, C., V. A. Fitzgerald, S. J. Dakin, and R. J. Behme.1987. Labo-ratory investigation of outbreak of hemorrhagic colitis caused byEscherichia coliO157:H7. J. Clin. Microbiol.25:1043–1047.

17. Kudoh, Y., A. Kai, H. Obata, J. Kusunoki, C. Monma, M. Shingaki, Y. Yanagawa, S. Yamada, S. Matsushita, T. Itoh, and K. Ohta.1994. Epide-miological surveys on verocytotoxin-producingEscherichia coliinfections in Japan, p. 53–56,InM. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producingEscherichia coliinfections. Elsevier Science Pub-lishers, Amsterdam, The Netherlands.

18. Leclercq, A., B. Lambert, D. Pierard, and J. Mahillon.2001. Particular biochemical profiles for enterohemorrhagicEscherichia coliO157:H7 iso-lates on the ID 32E system. J. Clin. Microbiol.39:1161–1164.

19. MacFaddin, J. F.1980. Biochemical tests for identification of medical bac-teria, 2nd ed. Williams & Wilkins, Baltimore, Md.

20. National Institute of Infectious Diseases.May 2000, posting date. Serotyping of non-O157 enterohemorrhagicEscherichia coliisolates during 1997–1999 in Japan. Infect. Agents Surveillance Rep.21:94. [Online.] http://idsc.nih .go.jp/iasr/21/243/de2431.html.

21. Oku, Y., Y. Uesaka, T. Hirayama, and Y. Takeda.1988. Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol. Immunol.32:807–816.

22. Old, D. C., and P. B. Crichton.1986. P fimbriation among biochemically inactive strains ofEscherichia coliof the group formerly called Alkalescens-Dispar. J. Med. Microbiol.21:337–342.

23. Ørskov, F.1984. Genus I.EscherichiaCastellani and Chalmers 1919, 941AL,

p. 420–423.InN. R. Krieg and J. G. Holt (ed.), Bergey’s manual of system-atic bacteriology, vol. 1. Williams & Wilkins, Baltimore, Md.

24. Park, C. H., N. M. Vandel, and D. L. Hixon.1996. Rapid immunoassay for

detection ofEscherichia coliO157 directly from stool specimens. J. Clin. Microbiol.34:988–990.

25. Park, C. K., H. J. Kim, and D. L. Hixon.2002. Importance of testing stool specimens for Shiga toxins. J. Clin. Microbiol.40:3542–3543. (Erratum,41:

526, 2003.)

26. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen.1983. Hemorrhagic colitis associated with a rare Esche-richia coliserotype. N. Engl. J. Med.308:681–685.

27. Scotland, S. M., G. A. Willshaw, B. Said, H. R. Smith, and B. Rowe.1989. Identification ofEscherichia colithat produces heat-stable enterotoxin STA

by a commercially available enzyme-linked immunoassay and comparison of the assay with infant mouse and DNA probe tests. J. Clin. Microbiol.27:

1697–1699.

28. Smith, H. R., and S. M. Scotland.1993. ACP broadsheet 135: January 1993. Isolation and identification methods forEscherichia coliO157 and other Vero cytotoxin producing strains. J. Clin. Pathol.46:10–17.

29. Thompson, J. S., D. S. Hodge, and A. A. Borczyk.1990. Rapid biochemical test to identify verocytotoxin-positive strains ofEscherichia coliserotype O157. J. Clin. Microbiol.28:2165–2168.

30. Vernozy-Rozand, C.1999. Verotoxin-producingEscherichia coli(VTEC) and Escherichia coliO157:H7 in medicine and food industry. Ann. Biol. Clin.

57:507–515.

31. Ware, J. M., S. L. Abbott, and J. M. Janda.2000. A new diagnostic problem: isolation ofEscherichia coliO157:H7 strains with aberrant biochemical prop-erties. Diagn. Microbiol. Infect. Dis.38:185–187.

32. World Health Organization.1996. EnterohaemorrhagicEscherichia coli in-fection. Wkly. Epidemiol. Rec.30:229–230.

on May 15, 2020 by guest

http://jcm.asm.org/

(6)

ERRATUM

Nissui Glucose Fermentative Gram-Negative Rod Identification System EB-20

Gives a Unique Profile for Typical Non-Sorbitol-Fermenting

Escherichia coli

O157:H7

H. Kodaka, Y. Uesaka, and F. Kashitani

Department of Microbiology, School of Medicine, Toho University, Otaku, Tokyo 143-8540, and Nissui Pharmaceutical Co. Ltd., Yuki, Ibaraki 307-0036, Japan

Volume 42, no. 1, p. 354–358, 2004. Page 356, Table 1, column 3, row 21: “9 (100)” should read “92 (100).”

Figure

TABLE 1. Frequency of EB-20 profile numbers of STEC, EPEC, ETEC, and nonpathogenic E. coli

References

Related documents

RESEARCH ARTICLE Open Access Community based weighing of newborns and use of mobile phones by village elders in rural settings in Kenya a decentralised approach to health care provision

Penelitian ini dilakukan dengan menggunakan studi literature secara sistematis yang diperoleh dari buku-buku penunjang, jurnal dan juga media lain seperti internet

Thispaper discusses the disparities existing in the education sector in Kenya. Thepaper focuses on the challenges faced by the HI learners of secondary school level and beyond

Paul, who was the great apostle of Christianity in the first century and Dasuk, the representative spiritual figure of the Korean Church.. And we will calculate the aspects of how

Methodology: Blood pressure, serum myoglobin, HDL-cholesterol, total cholesterol, triglyceride, fasting plasma glucose, urine and serum albumin, urine and serum creatinine

Segmentation is the process of partitioning a digital image into several segments based on pixels. It is a vital and essential part of image examination system. Real

In the present work, the recent developed Unsteady Double Wake Model, USDWM, is used to si- mulate separated flows past a wind turbine airfoil at high angles of attack.. The solver

Firstly the proposed protocol will detect the black hole attack and after detection it will make the authorized node.Accroding to the proposed solution the source node